14 July 2014 by Paul Hassoun

Focusing on Inflammation and Immune Modification to Treat PH

All credits to Prof. Paul Hassoun FPVRI, Paul Hassoun, Professor of Medicine, Director, Pulmonary Hypertension Program at Johns Hopkins University, Baltimore- MD | United States

Presented at the 1st Annual Drug Discovery and Development Symposium, July 14-15th 2014, Bethesda, USA


Additional key-words:  inflammation,immune system,autoimmunity,endothelium,

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI